IL18 and neoplasm: To do this we administered anti-mouse IL-18 mAb, or isotype control mAb, to C57BL/6 mice during vaccination, one day prior to all of the vaccinations, for 3 weeks and the tumor volume was monitored up to 6 weeks after the tumor challenge.